A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function |
| |
Authors: | Giordano F J Gerber H P Williams S P VanBruggen N Bunting S Ruiz-Lozano P Gu Y Nath A K Huang Y Hickey R Dalton N Peterson K L Ross J Chien K R Ferrara N |
| |
Affiliation: | Cardiovascular Gene Therapy Program, Department of Medicine, Yale University School of Medicine, Boyer Center for Molecular Medicine, 295 Congress Avenue, Room 336C, New Haven, CT 06520, USA. Frank.Giordano@yale.edu |
| |
Abstract: | The role of the cardiac myocyte as a mediator of paracrine signaling in the heart has remained unclear. To address this issue, we generated mice with cardiac myocyte-specific deletion of the vascular endothelial growth factor gene, thereby producing a cardiomyocyte-specific knockout of a secreted factor. The hearts of these mice had fewer coronary microvessels, thinned ventricular walls, depressed basal contractile function, induction of hypoxia-responsive genes involved in energy metabolism, and an abnormal response to beta-adrenergic stimulation. These findings establish the critical importance of cardiac myocyte-derived vascular endothelial growth factor in cardiac morphogenesis and determination of heart function. Further, they establish an adult murine model of hypovascular nonnecrotic cardiac contractile dysfunction. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|